Marcel Peter Keller
5PUBLICATIONS
24CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (5)
Sort by Publication Date:
|Nov 24, 2024
Pharmacodynamics of the S1P1 receptor modulator cenerimod in a phase 2b randomised clinical trial in patients with moderate to severe SLE.Madeleine Suffiotti, Pijus Brazauskas, Marcel Peter Keller
|May 10, 2024
Discovery of the Clinical Candidate IDOR-1117-2520: A Potent and Selective Antagonist of CCR6 for Autoimmune Diseases.Emmanuel A Meyer, Andrew L Croxford, Carmela Gnerre
|Mar 08, 2023
Discovery of Clinical Candidate ACT-777991, a Potent CXCR3 Antagonist for Antigen-Driven and Inflammatory Pathologies.Emmanuel A Meyer, Päivi Äänismaa, Eric A Ertel
|Feb 15, 2022
In Vitro Characterization of Sphingosine 1-Phosphate Receptor 1 (S1P1) Expression and Mediated Migration of Primary Human T and B Cells in the Context of Cenerimod, a Novel, Selective S1P1 Receptor Modulator.Lisa Schlicher, Paulina Kulig, Audrey von Münchow
|Sep 12, 2020
Preclinical to clinical translation of cenerimod, a novel S1P1 receptor modulator, in systemic lupus erythematosus.Daniel S Strasser, Sylvie Froidevaux, Virginie Sippel
Pageof 1
Frequent Collaborators
2 joint publications
Daniel S Strasser
2 joint publications
Eva Caroff
2 joint publications
Mark Joseph Murphy
1 joint publications
Sylvie Froidevaux
1 joint publications
Virginie Sippel
1 joint publications
Estelle Gerossier
1 joint publications
Ursula Grieder
1 joint publications
Gabin M Pierlot
1 joint publications
Ruben de Kanter
1 joint publications
Enrico Vezzali
